For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of East Anglia

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: Quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Type
D - Journal article
Title of journal
The Lancet Oncology
Article number
-
Volume number
14
Issue number
3
First page of article
236
ISSN of journal
14702045
Year of publication
2013
URL
-
Number of additional authors
18
Additional information

I have made a substantial contribution to the conception and design of the study

I have made a substantial contribution to the organisation of the conduct of the study

I have made a substantial contribution to carrying out the study (including acquisition of study data)

I have made a substantial contribution to analysis and interpretation of study data

I have helped draft the output

I have critiqued the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
7
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-